Click Therapeutics snags $52m Series B

Click Therapeutics Inc, a provider of digital therapeutics as prescription medical treatments, has raised $52 million in Series B financing.

25 October 2021•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Healthcare